Enveric Biosciences, Inc. · NASDAQ:ENVB
Ayrton Capital LLC's stake in Enveric Biosciences, Inc. fell to 2.93% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Ayrton Capital LLC's stake in Enveric Biosciences, Inc. fell to 2.93%, 111,145 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 2.93%
- Shares
- 111,145
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 2.93% | 111,145 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 2.93% | 111,145 |
| Waqas Khatri | 2.93% | 111,145 |
Source
Related
- Enveric Biosciences, Inc.
- Ayrton Capital LLC
- Enveric Biosciences, Inc. shareholders
- Schedule 13G · Ayrton Capital LLC · Nov 13, 2025
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Coveney Kevin Michael · Jun 3, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026
- Form 4 · Pasqualone Frank · Jun 3, 2026